title: [Meta-analysis of efficacy and safety of liver transplantation in treating cholangiocarcinoma].
abstract: OBJECTIVE
  To evaluate the therapeutic efficacy and safety of liver transplantation for patients with cholangiocarcinoma.
  
  
  METHODS
  According to the requirements of Cochrane systematic review, a thorough literature search was performed in Pubmed/Medline, Embase and Cochrane Central Register electronic databases ranged between 1995 and 2009 in terms of the key words "liver transplantation", and "cholangiocarcinoma" or "cholangiocellular carcinoma" or "bile duct cancer". And restricted the articles published in the English language. Two reviewers independently screened the studies for eligibility, evaluated the quality and extracted the data from the eligible studies with confirmation by cross-checking. Data were processed for a meta-analysis by Stata 10 software with 1-, 3-, 5-year survival rates and incidence of complications.
  
  
  RESULTS
  A total of 14 clinical trials containing 605 patients were finally enrolled in this study. The overall 1-, 3-, 5-year pooled survival rates were 73% (95%CI: 0.65 - 0.80), 42% (95%CI: 0.33 - 0.51) and 39% (95%CI: 0.28 - 0.51), respectively. Of note, preoperative adjuvant therapies (OLT-PAT group) rendered the transplanted individuals comparably favorable outcomes with 1-, 3-, 5-year pooled survival rates of 83% (95%CI: 0.57 - 0.98), 57% (95%CI: 0.18 - 0.92) and 65% (95%CI: 0.40 - 0.87), respectively. In addition, the overall pooled incidence of complications was 62% (95%CI: 0.44 - 0.78), among which that of OLT-PAT group (58%, 95%CI: 0.20 - 0.92) was relatively acceptable compared to those of liver transplantation alone (61%, 95%CI: 0.33 - 0.85) and liver transplantation with extended bile duct resection (78%, 95%CI: 0.55 - 0.94).
  
  
  CONCLUSIONS
  In comparison to curative resection of cholangiocarcinoma with the 5-year survival rate reported from 20% to 40%, the role of liver transplantation alone is so limited, but neoadjuvant radiochemotherapy combined with liver transplantation can bring better short- and long-term prognosis.
authors: Department of Hepatobiliary Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
authors: Jin-yang
authors: JY
authors: Gu
authors: Jian-ling
authors: JL
authors: Bai
authors: Xiao-lei
authors: XL
authors: Shi
authors: Jian-xin
authors: JX
authors: Zhou
authors: Yu-dong
authors: YD
authors: Qiu
authors: Ya-fu
authors: YF
authors: Wu
authors: Chun-ping
authors: CP
authors: Jiang
authors: Xi-tai
authors: XT
authors: Sun
authors: Fang-gui
authors: FG
authors: Xu
authors: Yue
authors: Y
authors: Zhang
authors: Yi-tao
authors: YT
authors: Ding